top of page
Companies in the News
EBR Systems, Inc. Initiates Global Trial of World’s Only Wireless CRT Pacing Technology
Tiny Wireless Electrode Potentially Expands Heart Failure Therapy SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the...
Mar 7, 2018
Indigo Launches On-Farm Storage to Facilitate a Direct Farmer-to-Buyer Grain Marketplace
On-farm storage program enables identity preservation of grain and improves farm margins This U.S. program is a key step in building a...
Mar 1, 2018
Former Receptos Executives Launch Gossamer Bio, Inc., a New Biopharma Company Focused on Discovering
Co-founded by Faheem Hasnain and Sheila Gujrathi, M.D., former executive leadership of Receptos, Inc. Omega Funds founding seed investor...
Jan 4, 2018
Millendo Therapeutics acquires French biopharmaceutical company
Millendo Therapeutics acquires Alize Pharma in stock-based transaction Merger beefs up Millendo's congenital adrenal hyperplasia program...
Dec 21, 2017
Grain Craft & Indigo Announce Consumer-Driven Supply Agreement for One Million Bushels of Identi
• Indigo to provide Grain Craft with wheat that is sustainably produced, identity preserved, and meets enhanced milling quality...
Dec 12, 2017
Clinical Data for eFFECTOR Therapeutics’ Lead Candidate eFT508 Demonstrates Clinical Activity, Well-
Preclinical Data Shows Potential of eFT226 in B-cell Malignancies Data to be presented at the ASH 59th Annual Meeting and Exposition SAN...
Dec 11, 2017
Farming startup Indigo raises $203 million with help from Dubai fund
SAN FRANCISCO (Reuters) - Farming technology startup Indigo has raised more than $200 million from investors to fund its efforts to...
Dec 6, 2017
Indigo Corn™ Demonstrates Significant Yield Gains on Farms Experiencing Severe Water Stress
- Indigo Corn demonstrates a 30+ bushel per acre yield increase on farms under severe water stress - Indigo announces 47 cent per bushel...
Nov 20, 2017
eFFECTOR Therapeutics Presents Preclinical Data for eFT508 that Demonstrates Beneficial Immunologica
SAN DIEGO, November 10, 2017 – eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for...
Nov 10, 2017
bottom of page